Importantly, MAP2K4 has been demonstrated to be a direct activator of MAP kinases that promote human prostate cancer metastasis [42] and act as prognostic markers of osteosarcoma tumorigenesis [43]. Here, MAP2K4 is linked to prostate carcinoma.